-
Mashup Score: 3Tumor Board Tuesday 2023 Conversations - 9 month(s) ago
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
Source: integrityce.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 2Locally advanced lung cancer - 9 month(s) ago
Click on the article title to read more.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Tumor Board Tuesday 2023 - Integrity CE - 10 month(s) ago
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #TumorBoardTuesday Free #CME🔗 https://t.co/Gzqzvik9BR Question2⃣ 🤔What was the objective response rate (ORR) of both t…
-
-
Mashup Score: 2Tumor Board Tuesday 2023 - Integrity CE - 10 month(s) ago
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #TumorBoardTuesday Free #CME🔗 https://t.co/Gzqzvik9BR 🤔What treatment approach would you recommend for a 62-year-old w…
-
-
Mashup Score: 1Tumor Board Tuesday Evaluation 2023 (ID: i854/i855/i862/i865) - 11 month(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Tumor Board Tuesday 2023 - Integrity CE - 11 month(s) ago
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Home - Integrity CE - 12 month(s) ago
Free New & Emerging Biologic Agents in CRSwNP: Pathophysiology Insights & Patient Selection Criteria Category: Immunology Expires: April 28, 2023 Length: 60 minutes Type: Online Offering: Integrity CE Start…
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Tumor Board Tuesday 2023 - Integrity CE - 1 year(s) ago
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Tumor Board Tuesday 2023 - Integrity CE - 1 year(s) ago
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
Source: Integrity CECategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TumorBoardTues: #TumorBoardTuesday #PreTest Q 2️⃣ Free #CME 🔗 https://t.co/Gzqzvik9BR 🤔What 5L would you pick for👆🏽46yoW with G3 NET (…
-
-
Mashup Score: 2
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions – Full Text View.
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet
RT @TumorBoardTues: #TumorBoardTuesday Free #CME🔗 https://t.co/Gzqzvik9BR Question2⃣ 🤔What subsequent Tx would you select for your 62yo…